Alzheimer's disease trials recruiting in Alabama

All Alzheimer's disease trials nationally

Cities in Alabama

Recruiting trials in Alabama

• A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
  NCT06566170 · Phase: Not specified · Ages: 60 Years and older · Sex: All (male and female) · Alabama: Huntsville
• A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
  NCT05552157 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
  NCT07169578 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Alabama: Birmingham
• A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
  NCT06647498 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
  NCT05511363 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Alabama: Homewood
• Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
  NCT07146412 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years to 75 Years · Sex: All (male and female) · Alabama: Huntsville
• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
  NCT05980949 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Alabama: Homewood
• Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
  NCT07177352 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Alabama: Birmingham
• Strengthening Health and Insight in New Educators
  NCT06745934 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Tuscaloosa
• Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
  NCT06808984 · Phase: Phase 2 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Alabama: Homewood, Huntsville
• UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy
  NCT03503331 · Phase: Phase 2 · Ages: 50 Years and older · Sex: All (male and female) · Alabama: Birmingham
• UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy
  NCT03809351 · Phase: Phase 1 · Ages: 50 Years and older · Sex: All (male and female) · Alabama: Birmingham